APO RESEARCH · REPORT
Heparin
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
Product & engineering
Understand the product.
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
Selected research
Industry Research
Heparin Industry Research Report 2026
Market perspective
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium Raw Material Drug is the largest segment, with a share about 96%. And in terms of application, the largest application is Low Molecular Weight Heparin Preparation, followed by Standard Heparin Preparation.
Report Scope
Read the full market overview
This report quantifies the global Heparin market in revenue (US$ million) and, where applicable, sales volume (B Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/B Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Heparin.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Heparin Market by Company
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio
Heparin Segment by Type
Heparin Sodium Raw Material Drug
Heparin Calcium Raw Material Drug
Heparin Segment by Application
Low Molecular Weight Heparin Preparation
Standard Heparin Preparation
Heparin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Heparin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Heparin Sodium Raw Material Drug
- Heparin Calcium Raw Material Drug
Applications
- Low Molecular Weight Heparin Preparation
- Standard Heparin Preparation
Companies covered
- Hepalink
- Changshan Pharm
- Qianhong Bio-pharma
- Opocrin
- Pfizer
- Aspen Oss
- King-friend Biochemical Pharmaceutical
- Bioibérica
- Dongcheng Biochemicals
- Jiulong Biochemicals
- Tiandong
- Xinbai
- Yino Pharma
- Deebio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Heparin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Heparin Sodium Raw Material Drug
- 2.2.3 Heparin Calcium Raw Material Drug
- 2.3 Heparin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Low Molecular Weight Heparin Preparation
- 2.3.3 Standard Heparin Preparation
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Heparin Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Heparin Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Heparin Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Heparin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Heparin Production by Manufacturers (2021-2026)
- 3.2 Global Heparin Production Value by Manufacturers (2021-2026)
- 3.3 Global Heparin Average Price by Manufacturers (2021-2026)
- 3.4 Global Heparin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Heparin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Heparin Manufacturers, Product Type & Application
- 3.7 Global Heparin Manufacturers Established Date
- 3.8 Global Heparin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hepalink
- 4.1.1 Hepalink Heparin Company Information
- 4.1.2 Hepalink Heparin Business Overview
- 4.1.3 Hepalink Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Hepalink Product Portfolio
- 4.1.5 Hepalink Recent Developments
- 4.2 Changshan Pharm
- 4.2.1 Changshan Pharm Heparin Company Information
- 4.2.2 Changshan Pharm Heparin Business Overview
- 4.2.3 Changshan Pharm Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Changshan Pharm Product Portfolio
- 4.2.5 Changshan Pharm Recent Developments
- 4.3 Qianhong Bio-pharma
- 4.3.1 Qianhong Bio-pharma Heparin Company Information
- 4.3.2 Qianhong Bio-pharma Heparin Business Overview
- 4.3.3 Qianhong Bio-pharma Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Qianhong Bio-pharma Product Portfolio
- 4.3.5 Qianhong Bio-pharma Recent Developments
- 4.4 Opocrin
- 4.4.1 Opocrin Heparin Company Information
- 4.4.2 Opocrin Heparin Business Overview
- 4.4.3 Opocrin Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Opocrin Product Portfolio
- 4.4.5 Opocrin Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Heparin Company Information
- 4.5.2 Pfizer Heparin Business Overview
- 4.5.3 Pfizer Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Pfizer Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Aspen Oss
- 4.6.1 Aspen Oss Heparin Company Information
- 4.6.2 Aspen Oss Heparin Business Overview
- 4.6.3 Aspen Oss Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Aspen Oss Product Portfolio
- 4.6.5 Aspen Oss Recent Developments
- 4.7 King-friend Biochemical Pharmaceutical
- 4.7.1 King-friend Biochemical Pharmaceutical Heparin Company Information
- 4.7.2 King-friend Biochemical Pharmaceutical Heparin Business Overview
- 4.7.3 King-friend Biochemical Pharmaceutical Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 King-friend Biochemical Pharmaceutical Product Portfolio
- 4.7.5 King-friend Biochemical Pharmaceutical Recent Developments
- 4.8 Bioibérica
- 4.8.1 Bioibérica Heparin Company Information
- 4.8.2 Bioibérica Heparin Business Overview
- 4.8.3 Bioibérica Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Bioibérica Product Portfolio
- 4.8.5 Bioibérica Recent Developments
- 4.9 Dongcheng Biochemicals
- 4.9.1 Dongcheng Biochemicals Heparin Company Information
- 4.9.2 Dongcheng Biochemicals Heparin Business Overview
- 4.9.3 Dongcheng Biochemicals Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Dongcheng Biochemicals Product Portfolio
- 4.9.5 Dongcheng Biochemicals Recent Developments
- 4.10 Jiulong Biochemicals
- 4.10.1 Jiulong Biochemicals Heparin Company Information
- 4.10.2 Jiulong Biochemicals Heparin Business Overview
- 4.10.3 Jiulong Biochemicals Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Jiulong Biochemicals Product Portfolio
- 4.10.5 Jiulong Biochemicals Recent Developments
- 4.11 Tiandong
- 4.11.1 Tiandong Heparin Company Information
- 4.11.2 Tiandong Heparin Business Overview
- 4.11.3 Tiandong Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Tiandong Product Portfolio
- 4.11.5 Tiandong Recent Developments
- 4.12 Xinbai
- 4.12.1 Xinbai Heparin Company Information
- 4.12.2 Xinbai Heparin Business Overview
- 4.12.3 Xinbai Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Xinbai Product Portfolio
- 4.12.5 Xinbai Recent Developments
- 4.13 Yino Pharma
- 4.13.1 Yino Pharma Heparin Company Information
- 4.13.2 Yino Pharma Heparin Business Overview
- 4.13.3 Yino Pharma Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Yino Pharma Product Portfolio
- 4.13.5 Yino Pharma Recent Developments
- 4.14 Deebio
- 4.14.1 Deebio Heparin Company Information
- 4.14.2 Deebio Heparin Business Overview
- 4.14.3 Deebio Heparin Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Deebio Product Portfolio
- 4.14.5 Deebio Recent Developments
5 Global Heparin Production by Region
- 5.1 Global Heparin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Heparin Production by Region: 2021-2032
- 5.2.1 Global Heparin Production by Region: 2021-2026
- 5.2.2 Global Heparin Production Forecast by Region (2027-2032)
- 5.3 Global Heparin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Heparin Production Value by Region: 2021-2032
- 5.4.1 Global Heparin Production Value by Region: 2021-2026
- 5.4.2 Global Heparin Production Value Forecast by Region (2027-2032)
- 5.5 Global Heparin Market Price Analysis by Region (2021-2026)
- 5.6 Global Heparin Production and Value, YOY Growth
- 5.6.1 North America Heparin Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Heparin Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Heparin Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Heparin Production Value Estimates and Forecasts (2021-2032)
6 Global Heparin Consumption by Region
- 6.1 Global Heparin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Heparin Consumption by Region (2021-2032)
- 6.2.1 Global Heparin Consumption by Region: 2021-2026
- 6.2.2 Global Heparin Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Heparin Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Heparin Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Heparin Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Heparin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Heparin Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Heparin Production by Type (2021-2032)
- 7.1.1 Global Heparin Production by Type (2021-2032) & (B Units)
- 7.1.2 Global Heparin Production Market Share by Type (2021-2032)
- 7.2 Global Heparin Production Value by Type (2021-2032)
- 7.2.1 Global Heparin Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Heparin Production Value Market Share by Type (2021-2032)
- 7.3 Global Heparin Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Heparin Production by Application (2021-2032)
- 8.1.1 Global Heparin Production by Application (2021-2032) & (B Units)
- 8.1.2 Global Heparin Production Market Share by Application (2021-2032)
- 8.2 Global Heparin Production Value by Application (2021-2032)
- 8.2.1 Global Heparin Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Heparin Production Value Market Share by Application (2021-2032)
- 8.3 Global Heparin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Heparin Value Chain Analysis
- 9.1.1 Heparin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Heparin Production Mode & Process
- 9.2 Heparin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Heparin Distributors
- 9.2.3 Heparin Customers
10 Global Heparin Analyzing Market Dynamics
- 10.1 Heparin Industry Trends
- 10.2 Heparin Industry Drivers
- 10.3 Heparin Industry Opportunities and Challenges
- 10.4 Heparin Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst